<DOC>
	<DOCNO>NCT02684240</DOCNO>
	<brief_summary>This research do determine Nitazoxanide ( NTZ ) cause significant decrease number M. tuberculosis bacteria sputum 14 day treatment . The study conduct GHESKIO Centers Port au Prince Haiti</brief_summary>
	<brief_title>A 14 Day Early Bactericidal Activity Study Nitazoxanide Treatment Tuberculosis</brief_title>
	<detailed_description>This prospective randomize two-arm 14-day , early bactericidal activity study treatment-naive , drug-susceptible patient uncomplicated pulmonary tuberculosis ( TB ) . The study conduct GHESKIO Centers Port au Prince Haiti . Twenty patient randomized receive NTZ 1 gram orally twice daily 14 day . Ten patient randomized positive control receive standard 4 drug tuberculosis therapy isoniazid ( H ) , rifampin ( R ) , ethambutol ( E ) , pyrazinamide ( PZA ) . Patients ' sputum collect every two day 14 day treatment , primary endpoint change number M. tuberculosis patient ' sputum . Our primary hypothesis NTZ result significant decrease number M. tuberculosis sputum during14 day treatment . The number M. tuberculosis quantify time positive ( TTP ) signal hour automate liquid medium culture system ( BACTEC MGIT 960 , Becton Dickinson ) .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Rifampin</mesh_term>
	<mesh_term>Isoniazid</mesh_term>
	<mesh_term>Pyrazinamide</mesh_term>
	<mesh_term>Ethambutol</mesh_term>
	<mesh_term>Nitazoxanide</mesh_term>
	<criteria>Men woman age 18 65 Diagnosed pulmonary tuberculosis via : sputummicroscopy smearpositive ( 2+ 3+ ) within 14 day plus Sputum GeneXpert positive within 14 day plus Chest radiograph consistent M. tuberculosis within 14 day TB treatment na√Øve time enrollment Bodyweight &gt; 40kg Negative HIV test within 30 day Able complete activity daily live ( ADLs ) All participant must agree participate conception process ( i.e . active attempt become pregnant impregnate , donate sperm , vitro fertilization ) All female participant must agree use barrier method condom well hormonal contraception dual prophylaxis . Able give inform consent demonstrate understanding study willingness participate study Willing hospitalize 2 week Pregnancy Evidence complication M. tuberculosis hemoptysis shortness breath Extrapulmonary manifestation M. tuberculosis History prior active tuberculosis Evidence rifampin resistance via GeneXpert Previous diagnosis diabetes suggestion impair glucose metabolism via random plasma glucose Previous diagnosis HIV rapid HIV test ELISA Any follow lab abnormality : Creatinine &gt; 1.5 time ULN ; Random glucose &gt; 2 time ULN ; ALT , AST , alkaline phosphatase &gt; 2 time ULN ; Hemoglobin &lt; 7.5 g/dL Any participant currently take antimycobacterial therapy within past 30 day Any concomitant illness could compromise patient safety trial renal failure , chronic liver disease alcoholic dependency Enrolled another clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>